The 2021 ASCO annual meeting features results from several breast cancer clinical trials that aim to propel the field forward, from a potentially new indication for olaparib to a less toxic chemotherapy regimen for metastatic breast cancer.
Clinical trialsExperimental modelsAdvances in diagnosis and treatmentsThe first Buenos Aires Breast Cancer Symposium (BA-BCS) was held in a virtual format, between the 17 th and the 21 st of May 2021. The main goal of the meeting was to facilitate the interaction among physicians and basic ...
January 11, 2021 A breast cancer vaccine can now be tested in human trials after its investigational new ... ARX788 on FDA Fast Track for Advanced HER2-positive Breast Cancers January 7, 2021 Conditional Approval Urged in EU for Trastuzumab Deruxtecan ...
Cancer Res. 79 (Suppl. 13), Abstr. 1538 (2019). Article Google Scholar Rugo, H. S. et al. Efficacy of margetuximab vs trastuzumab in patients with pretreated ERBB2-positive advanced breast cancer: a phase 3 randomized clinical trial. JAMA Oncol. 7, 573–584 (2021). Article Google ...
One of the leading causes of death (20.1 per 100,000 women per year), breast cancer is the most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as adenocarcinomas, and 55% of all patients may go into invasive phases; howe
◆ 会议时间:2021年12月7日至10日 线上+线下 ◆ 会议地点:美国 圣安东尼奥/San Antonio, TX - Henry B. Gonzalez Convention Center ◆ 下次会议:2022年第45届圣安东尼奥乳腺癌研讨会(SABCS2022) ◆ 会议简介: 圣安东尼奥乳腺癌研讨会(SABCS)是世界上最大、最具影响力的乳腺癌会议,自1977年以来,从一个为期...
Cancer Research 2010 Q2 Cancer Research 2011 Q2 Cancer Research 2012 Q2 Cancer Research 2013 Q2 Cancer Research 2014 Q2 Cancer Research 2015 Q2 Cancer Research 2016 Q2 Cancer Research 2017 Q3 Cancer Research 2018 Q2 Cancer Research 2019 Q2 Cancer Research 2020 Q3 Cancer Research 2021 Q3 Cancer Re...
Although Ki-67 is a commonly used measure of cellular proliferation in breast cancer tissue, its utility as a biomarker for helping to guide therapy decisions has been clouded by technical and clinical questions.
Unlocking the potential of antibody-drug conjugates for cancer therapy. Nat Rev Clin Oncol. 2021;18(6):327–44. Drake PM, Rabuka D. Recent developments in ADC technology: preclinical studies signal future clinical trends. BioDrugs. 2017;31(6):521–31. https://doi.org/10.1007/s40259-017-...
Table 1. Completed clinical feasibility trials utilizing percutaneous biopsy after neoadjuvant therapy to select patients for omission of breast cancer surgery (partially adapted from Kuerer et al.24) Group/author/PIEligibility criteria/lesion size criteriaType of biopsyNumber of patientsStudy unique chara...